Aura Biosciences, Inc.
Aura Biosciences, Inc.（AURA）内幕交易
基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签；可在本季度与近12个月之间切换；下方为季度图与交易明细。
SEC EDGAR · FMP · AURA · 截至 2026年6月8日
活动摘要
买入笔数
0
P-Purchase only
卖出笔数
14
近12个月
买卖比
0.00
Buy/Sell (by trades)
整体情绪
Aura Biosciences, Inc.内部人在过去近12个月主要在卖出股份，卖出行为通常由预设的Rule 10b5-1计划驱动，不一定代表对公司的负面看法。
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale
截至 2026年6月8日
AURA 季度内部人买卖趋势
AURA 内幕交易卖出 · AURA 内幕交易买入 · 季度活动
Mobile shows last 4Q · Desktop shows full 8Q
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 最近8季度
As of Jun 8, 2026
活跃内部人
近12个月交易最活跃 · AURA CEO内幕交易
显示全部内部人 · 点击卡片过滤下方交易表
▸ 按reportingName聚合 · 近12月交易次数Top5 · 无额外API
近期内幕交易记录
AURA 高管卖出股份 · AURA 董事内幕交易 · SEC Form 4申报
横向滑动查看全部列
| 日期 | 内部人 | 类型 | 股数 | 总金额 | 申报 |
|---|---|---|---|---|---|
| May 19, 2026 | Holles Natalie C. See Remarks · Director | Award | 553,844 | — | Form 4 |
| May 19, 2026 | Holles Natalie C. See Remarks · Director | Award | 600,118 | — | Form 4 |
| Apr 16, 2026 | Kilroy Conor See Remarks | Sale | 11,738 | $82K | Form 4 |
| Mar 2, 2026 | Kilroy Conor See Remarks | Award | 62,339 | — | Form 4 |
| Mar 2, 2026 | Gibney Anthony S See Remarks | Award | 71,245 | — | Form 4 |
| Mar 2, 2026 | de los Pinos Elisabet See Remarks · Director | Award | 166,000 | — | Form 4 |
| Mar 2, 2026 | Plavsic Mark CTO | Award | 62,339 | — | Form 4 |
| Mar 2, 2026 | Hopkins Janet Jill Chief Medical Officer | Award | 89,056 | — | Form 4 |
| Mar 2, 2026 | Elazzouzi Amy Senior Vice President, Finance | Award | 44,528 | — | Form 4 |
| Feb 17, 2026 | Kilroy Conor See Remarks | Sale | 12,079 | $61K | Form 4 |
| Feb 17, 2026 | Plavsic Mark CTO | Sale | 15,890 | $80K | Form 4 |
| Feb 17, 2026 | Hopkins Janet Jill Chief Medical Officer | Sale | 20,401 | $103K | Form 4 |
| Feb 17, 2026 | Elazzouzi Amy Senior Vice President, Finance | Sale | 8,549 | $43K | Form 4 |
| Feb 17, 2026 | de los Pinos Elisabet See Remarks · Director | Sale | 47,648 | $241K | Form 4 |
| Jan 20, 2026 | Elazzouzi Amy Senior Vice President, Finance | Sale | 1,581 | $8K | Form 4 |
| Jan 20, 2026 | de los Pinos Elisabet See Remarks · Director | Sale | 16,928 | $82K | Form 4 |
| Nov 17, 2025 | Hopkins Janet Jill Chief Medical Officer | Sale | 17,109 | $93K | Form 4 |
| Oct 29, 2025 | Elazzouzi Amy Senior Vice President, Finance | Sale | 896 | $6K | Form 4 |
| Oct 29, 2025 | de los Pinos Elisabet See Remarks · Director | Sale | 9,049 | $57K | Form 4 |
| Oct 16, 2025 | Plavsic Mark CTO | Sale | 12,169 | $77K | Form 4 |
| Aug 18, 2025 | Elazzouzi Amy Senior Vice President, Finance | Option | 2,319 | $10K | Form 4 |
| Aug 18, 2025 | Elazzouzi Amy Senior Vice President, Finance | Option | 1,094 | $3K | Form 4 |
| Aug 18, 2025 | Elazzouzi Amy Senior Vice President, Finance | Option | 4,744 | $13K | Form 4 |
| Aug 18, 2025 | Elazzouzi Amy Senior Vice President, Finance | Sale | 7,722 | $52K | Form 4 |
| Aug 18, 2025 | Elazzouzi Amy Senior Vice President, Finance | Option | 547 | $3K | Form 4 |
de los Pinos Elisabet
See Remarks · Director
日期
Feb 17
股数
47,648
均价
$5.06
总金额
$241K
Elazzouzi Amy
Senior Vice President, Finance
日期
Aug 18
股数
2,319
均价
$4.25
总金额
$10K
Elazzouzi Amy
Senior Vice President, Finance
日期
Aug 18
股数
4,744
均价
$2.74
总金额
$13K
⚡ = 金额≥$100万 · Award/Option价格显示— · 仅Form4 · 仅普通股
▸ 数据来源：SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —
关于 AURA 内幕交易
AURA 内幕交易
Aura Biosciences, Inc.（AURA）内幕交易数据来源于公司内部人（包括Elazzouzi Amy (Senior Vice President, Finance), de los Pinos Elisabet (See Remarks · Director), Kilroy Conor (See Remarks)）提交的SEC Form 4申报文件。过去12个月内，5位内部人向SEC提交了交易申报。AURA内部人近期主要在卖出，这可能反映预设的10b5-1计划执行，而非方向性判断。
如需查看Aura Biosciences, Inc.机构持仓比例和内部人持股百分比，请访问持仓（Ownership）标签页 → Ownership tab →
常见问题
AURA 内幕交易 · 5个问题Aura Biosciences, Inc.（AURA）的内部人包括高管和董事，如Elazzouzi Amy (Senior Vice President, Finance), de los Pinos Elisabet (See Remarks · Director), Kilroy Conor (See Remarks)等。过去12个月内，5位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。
▸ 数据来源：FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 8, 2026